| Dr Lance Hamilton Borup, DO | |
|
525 Branson Landing Blvd, Branson, MO 65616-2052 | |
| (417) 875-3000 | |
| Not Available |
| Full Name | Dr Lance Hamilton Borup |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 23 Years |
| Location | 525 Branson Landing Blvd, Branson, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356320436 | NPI | - | NPPES |
| 1356320436 | Medicaid | MO | |
| 200614030D | Medicaid | KS | |
| 204512701 | Medicaid | MO | |
| 200202290A | Medicaid | OK |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cox Medical Center Branson | Branson, MO | Hospital |
| Cox Medical Centers | Springfield, MO | Hospital |
| Mercy Hospital Springfield | Springfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lester E Cox Medical Centers | 1658509864 | 39 |
News Archive
ICON plc,, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the official opening of a purpose-built clinical pharmacology unit within the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. Initial studies in the unit utilising translational medicine methodologies to expedite drug development projects began in June, and already 110 volunteers have participated in studies there.
A.P. Pharma, a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two tranches, the first consisting of common stock and warrants with aggregate proceeds of approximately $8.1 million, and a second tranche of common stock with proceeds of approximately $5 million.
MDR-TB is tuberculosis, a mycobacterial infection, that has developed resistance to two important and powerful first-line anti-TB drugs, INH and rifampin.
A recent study examined the risks of SARS-CoV-2 infection during pregnancy, finding that no severe adverse outcomes are expected to either party.
BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its 2009 second quarter financial results.
› Verified 7 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760405864 PECOS PAC ID: 8628092897 Enrollment ID: O20060116000342 |
News Archive
ICON plc,, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the official opening of a purpose-built clinical pharmacology unit within the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. Initial studies in the unit utilising translational medicine methodologies to expedite drug development projects began in June, and already 110 volunteers have participated in studies there.
A.P. Pharma, a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two tranches, the first consisting of common stock and warrants with aggregate proceeds of approximately $8.1 million, and a second tranche of common stock with proceeds of approximately $5 million.
MDR-TB is tuberculosis, a mycobacterial infection, that has developed resistance to two important and powerful first-line anti-TB drugs, INH and rifampin.
A recent study examined the risks of SARS-CoV-2 infection during pregnancy, finding that no severe adverse outcomes are expected to either party.
BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its 2009 second quarter financial results.
› Verified 7 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174952212 PECOS PAC ID: 1658509864 Enrollment ID: O20140115001602 |
News Archive
ICON plc,, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the official opening of a purpose-built clinical pharmacology unit within the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. Initial studies in the unit utilising translational medicine methodologies to expedite drug development projects began in June, and already 110 volunteers have participated in studies there.
A.P. Pharma, a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two tranches, the first consisting of common stock and warrants with aggregate proceeds of approximately $8.1 million, and a second tranche of common stock with proceeds of approximately $5 million.
MDR-TB is tuberculosis, a mycobacterial infection, that has developed resistance to two important and powerful first-line anti-TB drugs, INH and rifampin.
A recent study examined the risks of SARS-CoV-2 infection during pregnancy, finding that no severe adverse outcomes are expected to either party.
BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its 2009 second quarter financial results.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lance Hamilton Borup, DO 1202 Rustic Rdg, Joplin, MO 64804-3679 Ph: (417) 434-2991 | Dr Lance Hamilton Borup, DO 525 Branson Landing Blvd, Branson, MO 65616-2052 Ph: (417) 875-3000 |
News Archive
ICON plc,, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the official opening of a purpose-built clinical pharmacology unit within the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. Initial studies in the unit utilising translational medicine methodologies to expedite drug development projects began in June, and already 110 volunteers have participated in studies there.
A.P. Pharma, a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two tranches, the first consisting of common stock and warrants with aggregate proceeds of approximately $8.1 million, and a second tranche of common stock with proceeds of approximately $5 million.
MDR-TB is tuberculosis, a mycobacterial infection, that has developed resistance to two important and powerful first-line anti-TB drugs, INH and rifampin.
A recent study examined the risks of SARS-CoV-2 infection during pregnancy, finding that no severe adverse outcomes are expected to either party.
BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its 2009 second quarter financial results.
› Verified 7 days ago
Dr. Anthony Wheeler, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd, Branson, MO 65616 Phone: 417-335-7000 | |
Dr. Richard S Makuch, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd, Branson, MO 65616 Phone: 417-335-7000 | |
Dr. Veeral R Bhoot, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd, Branson, MO 65616 Phone: 417-875-3000 | |
Mittie M Dragosljvich, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd, Branson, MO 65616 Phone: 417-348-8032 Fax: 417-348-8152 |